Cytomegalovirus infection is a frequent complication after transplantation. This infection
occurs due to transmission from the transplanted organ, due to reactivation of latent …

The use of postdetection antiviral treatment of cytomegalovirus (CMV) as a strategy to
prevent infection and disease in solid-organ transplant patients has not been evaluated by …

We reviewed the epidemiologic characteristics, diagnosis, clinical features, and
management of cytomegalovirus (CMV) infection after renal transplantation. CMV, the major …

In this multicenter, randomized study, cytomegalovirus (CMV)-seropositive patients who
received an allogeneic bone marrow transplant were provided high-dose intravenous …

Cytomegalovirus (CMV) infection is common after lung transplantation. We performed a
prospective trial of valganciclovir prophylaxis in lung recipients with outcomes compared to …

Intravenous ganciclovir is the standard treatment for cytomegalovirus disease in solid organ
transplant recipients. Oral valganciclovir is a more convenient alternative. In a randomized …

Background. Cytomegalovirus (CMV) infection is the single most frequent infectious
complication inrenal transplant recipients. Because no CMV-prophylaxis is given and …

Background Cytomegalovirus (CMV) disease is a major complication of organ
transplantation. We hypothesized that prophylactic treatment with valacyclovir would reduce …

Late‐onset cytomegalovirus (CMV) disease is a significant problem in D+/R− solid organ
transplant (SOT) patients who receive antiviral prophylaxis. We assessed the clinical utility of …

The natural history of cytomegalovirus (CMV) disease associated with solid organ
transplantation has been modified as a result of the widespread use of antiviral prophylaxis …